| Literature DB >> 10686055 |
C M Nübling1, M Chudy, J Löwer.
Abstract
Validation of HCV-NAT assays is an important prerequisite for the use of NAT for screening plasma or blood donations. The main NAT features to be validated are specificity, detection limit and robustness. Preliminary experience in Germany obtained with different methodical and logistic approaches shows the feasibility of HCV-NAT as a screening test for blood donations.Mesh：
Substances：
Year: 1999 PMID： 10686055 DOI： 10.1006/biol.1999.0223
Source DB: PubMed Journal: Biologicals ISSN： 1045-1056 Impact factor: 1.856